0001437749-21-022683.txt : 20210927 0001437749-21-022683.hdr.sgml : 20210927 20210927163036 ACCESSION NUMBER: 0001437749-21-022683 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210927 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210927 DATE AS OF CHANGE: 20210927 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASENSUS SURGICAL, INC. CENTRAL INDEX KEY: 0000876378 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 112962080 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-19437 FILM NUMBER: 211282063 BUSINESS ADDRESS: STREET 1: 1 TW ALEXANDER DRIVE STREET 2: SUITE 160 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-765-8400 MAIL ADDRESS: STREET 1: 1 TW ALEXANDER DRIVE STREET 2: SUITE 160 CITY: DURHAM STATE: NC ZIP: 27703 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX, INC. DATE OF NAME CHANGE: 20190712 FORMER COMPANY: FORMER CONFORMED NAME: TRANSENTERIX INC. DATE OF NAME CHANGE: 20131210 FORMER COMPANY: FORMER CONFORMED NAME: SafeStitch Medical, Inc. DATE OF NAME CHANGE: 20080211 8-K 1 transe20210927_8k.htm FORM 8-K transe20210927_8k.htm
false 0000876378 0000876378 2021-09-27 2021-09-27
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
 
September 27, 2021
Date of Report (date of earliest event reported)
 
 
Asensus Surgical, Inc.
(Exact name of Registrant as specified in its charter)
 
 
Delaware
(State or other jurisdiction of
incorporation or organization)
  
0-19437
(Commission
File Number)
  
11-2962080
(I.R.S. Employer
Identification Number)
 
1 TW Alexander Drive, Suite 160
Durham, NC 27703
(Address of principal executive offices)
 
919-765-8400
(Registrant’s telephone number, including area code)
 
Not Applicable
(Former name or former address, if changed since last report)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
☐  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading symbol
  
Name of each exchange on which registered
Common Stock
$0.001 par value per share
  
ASXC
  
NYSE American
 
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
 
 
 
 
 
Item 8.01
Other Events.
 
On September 27, 2021, Asensus Surgical, Inc., a Delaware corporation (the “Company”), issued a press release announcing Loginov Moscow Clinical Scientific Center, located in Moscow, Russia, has initiated its Senhance® Robotic Surgery program following the purchase of a Senhance Surgical System. The installation represents the first Senhance Surgical System to be used within Russia.
 
A copy of the press release is filed herewith as Exhibit 99.1 and incorporated herein by reference.
 
Item 9.01
Financial Statements and Exhibits.
 
(d)
Exhibit
 
 
Exhibit No.
Description
 
 
99.1
 
 
104
Cover Page Interactive Data File (formatted in inline XBRL)
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
ASENSUS SURGICAL, INC.
Date: September 27, 2021
/s/ Shameze Rampertab
Shameze Rampertab
Executive Vice President and Chief Financial Officer
 
 
 
2
 EX-99.1 2 ex_286646.htm EXHIBIT 99.1 ex_286646.htm

Exhibit 99.1

 

Asensus Surgical Announces Purchase of Senhance Robotic System by Loginov Moscow Clinical Scientific Center

 

Loginov Moscow is the first Russian hospital to initiate a Senhance Surgical System program

 

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- Sept. 27, 2021-- Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced that Loginov Moscow Clinical Scientific Center, located in Moscow, Russia, has initiated its Senhance® Robotic Surgery program following the purchase of a Senhance Surgical System. The installation represents the first Senhance Surgical System to be used within Russia.

 

“We are thrilled to be partnering with such an innovative, forward-thinking institution for our first Senhance program within Russia,” said Anthony Fernando, Asensus Surgical President and CEO. “We share a commitment to advancing patient outcomes through the use of new minimally invasive technologies and look forward to helping Loginov expand their offerings to patients.’’

 

Asensus Surgical's technology platform, Senhance Surgical System, is the first of its kind digital laparoscopic platform that leverages augmented intelligence to provide unmatched performance and patient outcomes through machine learning. Senhance goes beyond the typical surgical robotic systems, providing surgical assurance through haptic feedback, eye-tracking camera control, and 3D visualization, and is the first platform to offer 3 mm instruments (the smallest instrument available in the world on a robotic surgical platform). The Senhance Surgical System is powered by the Intelligent Surgical Unit™ (ISU™). The ISU enables machine vision-driven control of the camera for a surgeon by responding to commands and recognizing certain objects and locations in the surgical field, and allows a surgeon to change the visualized field of view using the movement of their instruments. The newest ISU features expand upon these capabilities and introduce more advanced features including: 3D measurement, digital tagging, image enhancement, and enhanced camera control based on real-time data from anatomical structures while performing surgery.

 

“Our team has been successfully and for many years developing minimally invasive surgical technologies that help our patients fast-track a return to an active life while preserving an optimal therapeutic approach. We are ready to utilize the Senhance Surgical System as part of our therapeutic options and hope that its use will allow us to achieve even safer and more reproducible surgery outcomes and ensure that a higher number of patients enjoy favorable effects of minimal invasive surgery", said Professor Igor Khatkov, Head of the Loginov Moscow Clinical Scientific Center.

 

 
 

 

About Loginov Moscow Clinical Scientific Center

 

The Loginov Moscow Clinical Scientific Center (The Loginov MCSC) is one of the largest and most innovative institutions funded by the Moscow Health Department. The Loginov MCSC is a multi-disciplinary clinical, research, and training center hosting 48 medical departments, employing around 500 doctors, and performing more than 13,000 annual operations. The Loginov MCSC is headed by Professor Igor Khatkov, a proponent of minimally invasive surgical technologies and a world leader in laparoscopic pancreatic surgery. Since its founding in July 2013, The Loginov MCSC has spent considerable resources on educational activities. The training center trains specialists in 12 medical specialties in residency and four specialties in fellowship. The center features a program for the development of robotic surgery, headed by Professor Nikolay Matveev, carried out in cooperation with the Department of Surgery of the Biomedical Faculty, Pirogov Russian National Research Medical University. To learn more please visit: https://mknc.ru/.

 

About Asensus Surgical, Inc.

 

Asensus Surgical, Inc. is digitizing the interface between the surgeon and patient to pioneer a new era of Performance-Guided Surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. This builds upon the foundation of Digital Laparoscopy with the Senhance Surgical System powered by the Intelligent Surgical Unit (ISU) to increase surgeon control and reduce surgical variability. With the addition of machine vision, augmented intelligence, and deep learning capabilities throughout the surgical experience, we intend to holistically address the current clinical, cognitive and economic shortcomings that drive surgical outcomes and value-based healthcare. Learn more about Performance-Guided Surgery and Digital Laparoscopy with the Senhance Surgical System here: www.senhance.com. Now available for sale in the US, EU, Japan, Russia, and select other countries. For a complete list of indications for use, visit: www.senhance.com/indications. For more information, visit www.asensus.com.

 

Forward-Looking Statements

 

This press release includes statements relating to the Senhance Surgical System and The Loginov Moscow Clinical Scientific Center hospital initiating a program with the Senhance System. These statements and other statements regarding our future plans and goals constitute "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control and which may cause results to differ materially from expectations and include whether the Senhance Surgical System will help Loginov Moscow Clinical Scientific Center expand their minimally invasive offerings to patients and whether the use of the Senhance Surgical System will allow Loginov Moscow Clinical Scientific Center to achieve even safer and more reproducible surgery outcomes and ensure that a higher number of patients enjoy favorable effects of minimal invasive surgery. For a discussion of the risks and uncertainties associated with the Company’s business, please review our filings with the Securities and Exchange Commission (SEC), including our Annual Report on Form 10-K for the year ended December 31, 2020, filed with the SEC on March 11, 2021 and our other filings we make with the SEC. You are cautioned not to place undue reliance on these forward looking statements, which are based on our expectations as of the date of this press release and speak only as of the origination date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

 

INVESTOR CONTACT:

Mark Klausner or Mike Vallie, 443-213-0499

invest@asensus.com

or

MEDIA CONTACT:

Kristin Schaeffer, 858-354-8850

CG Life

kschaeffer@cglife.com

 

 

 
 EX-101.SCH 3 asxc-20210927.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 asxc-20210927_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 asxc-20210927_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, Address Line Two Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security Trading Symbol Security Exchange Name Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 asxc-20210927_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 transe20210927_8k_htm.xml IDEA: XBRL DOCUMENT 0000876378 2021-09-27 2021-09-27 false 0000876378 8-K 2021-09-27 Asensus Surgical, Inc. DE 0-19437 11-2962080 1 TW Alexander Drive Suite 160 Durham NC 27703 919 765-8400 false false false false Common Stock ASXC NYSEAMER false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Document And Entity Information
Sep. 27, 2021
Document Information [Line Items]  
Entity, Registrant Name Asensus Surgical, Inc.
Document, Type 8-K
Document, Period End Date Sep. 27, 2021
Entity, Incorporation, State or Country Code DE
Entity, File Number 0-19437
Entity, Tax Identification Number 11-2962080
Entity, Address, Address Line One 1 TW Alexander Drive
Entity, Address, Address Line Two Suite 160
Entity, Address, City or Town Durham
Entity, Address, State or Province NC
Entity, Address, Postal Zip Code 27703
City Area Code 919
Local Phone Number 765-8400
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock
Trading Symbol ASXC
Security Exchange Name NYSEAMER
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000876378
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.asxc.com/20210927/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports transe20210927_8k.htm asxc-20210927.xsd asxc-20210927_def.xml asxc-20210927_lab.xml asxc-20210927_pre.xml ex_286646.htm http://xbrl.sec.gov/dei/2021 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "transe20210927_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "local": [ "asxc-20210927_def.xml" ] }, "inline": { "local": [ "transe20210927_8k.htm" ] }, "labelLink": { "local": [ "asxc-20210927_lab.xml" ] }, "presentationLink": { "local": [ "asxc-20210927_pre.xml" ] }, "schema": { "local": [ "asxc-20210927.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" ] } }, "elementCount": 27, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "asxc", "nsuri": "http://www.asxc.com/20210927", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "transe20210927_8k.htm", "contextRef": "d20218K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.asxc.com/20210927/role/statement-document-and-entity-information", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "transe20210927_8k.htm", "contextRef": "d20218K", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document, Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document, Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity, Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity, Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity, Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity, Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity, Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity, Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.", "label": "Entity [Domain]" } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity, Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity, File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity, Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity, Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity, Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "employerIdItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.asxc.com/20210927/role/statement-document-and-entity-information" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" } }, "version": "2.1" } ZIP 15 0001437749-21-022683-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-21-022683-xbrl.zip M4$L#!!0 ( ,N#.U.52+*S< , "<. 1 87-X8RTR,#(Q,#DR-RYX MTBTMTM5]JF-_G\]WCH^/3\_?;LN"_ 9MA)+S)!N-$P*2JUS(]3SY?I.^ MNWF_6"3$6"9S5B@)\T2JY.W%RQ?G_Z3I)Y"@F86<+._)[::6.>A+50*Y5MJR M@J1D2B=OZ&0\RIHV]-/C-\ R4CJ$&:V7:I"S%/-M96,TKO M[NY&;F:D]!HW&)]1(9T*#DG FSQ"WYT%;$;__7QUX_?NP(60/_O@V70ZI7XU M0*62LB[[A>164WM? 450BBC0@@>>L97N6)YA@(_6ZC=U*SX( ?I(3.RI6UXR MTWDZ0$XLQ0%R&XMI=W]%F\4 S4'TB\:%2#-7M;3ZOA_<+D8$(_B!< @>[UQK MC4EW:.MV-:+ EF_ZX6XE@C*SY5'TW,2(J]*CQM/)FX0P:[58UA8^*EU>PHK5 M!4:OEK]J5HB5@!QO10$E2!L!]I8MTVNP7U@)IF('C9/N[,CDLOUJX&YSN_P?A2;;0TS*97U>P0IK*J$7"GWZ1[;67AQO\&*^&9@QC1WA>OI MEH%66E6@K0"S_VC[#38:5O/$U?XTU/T?!5N.\%4*D$<&XOKM"R=2H+C:R0M< M=YOGB<&8%M"$^+]T)(?5L8X@14CA#N%_YTVEX5AOD&*P'6#'^>.HM[A$!+:N M^"Y;WU.DN>*U'V"3G>*OL/>I2T]=^OT3XGC?ORV>[BH:8<-W[53M3J9IF89T MIA?C\1C;^\O6QO[PG&ULU5I=C]HX%'U?:?]# MFGT.(.=Y7X "1P(B9[IV)O,EC8#?L02<$>,"$<=SVG[KO=]JM@*G MU0F"3M!V1@^>IVXGF/[HJ(\I2L&1-&B:GW;=N1"+CN^O5JM&-N6DP7@L0S1O M_!W:W<)5:R3V-QR";_U-XQYZ%'IUDV.#=KOMYZU[:(J+@#)HX/_]<#\.YY @ M#U.5DU!Q27$GS2_>LQ")/)&5$APM0IUY.YBG+GE!R[L)&ED:N?O$(1YR1N ) M9L[V\-O3\#@3F H_PHF_Q?B($$DXCS#G,-,2W:5/]7^K>O[MX$ZQ7LAID.)D M0<#UWTHI8@G"U$L@F0(_DUQAC O3Q E0M4J\36?G,M6$N2S9N8S&P^44O'U_ M9_(MB60MOS!#2R+>GN#7<31T=UQ_)JIZ0FD6-D*6Y!M8LRUWLIRJ7/@"9"]" MCF&XS _D[NC);RS6;K%*JI6 MU&Q(0"9 ;O<'6Q)AX=&0I;LA3R%LQ.S9CP#G_:N#/!F;00/\[R#O\.[5JB!H M"J3KZIHW3(C:=1D_R,?UF!1/LHLSNMN.S/!E-"9H2J" 717T>@SE7(2AG%JI M&%+,G78;)G)"#AFT8!&=W)G**%4B+.Z M)I\@QJG@B(JO*"FB5@:SRFPHBV:^8#R?RF.UI?;9D@J^[K-(3]3H+JN\/V," M7Y>'9=,1R6.(5483E TC]?29X4TU74&O F^5:R^*.*3I]DOM8(&69PGVRAQ; M)W!L79-C7QX^\@E;Z1^[6N0U^.4K])&/.'O&FU>_4I(:^#68CI@LZ\@_>%&Z M_92!+;%4 ]?C@#2\BIIMU0$R(!G-&=7O?SJ()4;?.1:RJ.ZS)%G2[6965)^4 MXBQQ&S."0_F*0>,'.:DY1J2 F!YDB=6(@\H"R-65UTCJC80_SF:%HUD-O@[+ M89HN@9_$57N+K=&&<"DGV3IH32=8%+YGZ""6&$TX4I[D>)U,6='4*VRWG)U! M%LX1C4%3BY;!K#X#!@GP6";C"V,L*7^19566BNRB2D1P<1&OG92S5!3;,3LUUQB4$K_T15&E M1\,,C(@75>?IVEYD5$ F!B1_SG3=%&)U<++N@Y\'2G4>NSSL%-_JBA.SZ">% MMTD[MG ,Y+1J*Z?$_C'0=5,[7=7>D8&LWVLJZP2GR4#E;4U5ZJPJ TE_U%22 MD;UEH.]]3?55VF(&VO[\WVAKG:RM76]M.B/.Y$%]J3K8DK12^\Y$7_TJ$5/; MST1=_0H3O7EHHJ=^!4FY_6BBJ7[5B(%W:2*L?@5(E?=IHJI^-8BI9VJBKGX5 MR&DNJXG&^E4BY3ZMB:;Z52 E9J_)&W7]ZHYJJ]A$5UWK#0.'V41>_0J.$IO: M1%#]*@X#C_O 3/5_TB;#_OBXOZX^U%^8Y97_ %!+ P04 " #+@SM3!A)H M5P\& !K/@ %0 &%S>&,M,C R,3 Y,C=?;&%B+GAM;,V;76_B1A2&[ROU M/TSI32NMXYBHK8@VNXJ2[ IM/E!@U:JKJC+V */:<]!X"/#O.S,&@F'&V(09 M[TTP^/B\Q^]Y[!E_Y/W'19J@%\PR O2J%9R=MQ"F$<2$CJ]:7_O>=?^FVVVA MC(M6:<#Z]]/WY?'ZV M&++D#-A8I#B_\-?1K56X7!OSS0;;P;_Y^@1*CV)9"T9N7 7D#%"?O/689[\R0O:WD5P MMLCBUL8X!@E^QB,D/[\^=XV*'5]&^!2/99ONPR%.1,4JQ83AD7Z[A+'"9K** MCJPB^%U6\;,N&U].!1L92:<);OEOK+.'&8'XCIZX8'U:"Y7W>^G/&W%XM2%3USQ7LJ35OR(3TS&;L)357M$F7R_Q$JU)3+F7BRM MPF2ZDI.H4EN=LK?2X@7'8@3:.DLF$.V5GZU'B@Q'9V-X\6-,U @E%SRYH"H7 M7_Z]HYSPI1C00D+74JK4JY9I=5Y)(@<"8+M[6)["2[:=JF3!OK4,9S!C43Y$ M"B4YC&/J?>VW/N1:Z%NN]L][_[688IG7;.U:R*(#=:PB_ C$6#CEQ7T8,4A+ MK()#'N2[)"24D2=JZKTX:I)<\WI!,DU?#1$U6[N3Q79WE1Q:]U@JNNVPR32H MX(:5/M]"-$LQY5TZ I:J>9DXP^ NQZFNZ57":Q)0EM(V#FMMM"6.ODEYI/3= MPE')7*CKFBML!N$PP=60*82^'1>5KAE4E'3CE!3]-!.B,6(2@2R-@4V!J?.ESP=\-S"AGRQN(S4Q4VNHH1$HSNR*F4,0[I,I P-"J M%"1K:0"C:J[#D79:A.P32?#C+!UB9B1J/^0H?%[3N&)%*J)\K#0W"TC=P7BB30PR9;9"+;^<E!QL/D M;S(MO4PN"WX+,X6$SHG)U9&0;^I"N-17'2TEAEEA19[0KAD.#73H5M?D83N% M;0+46"+%W/=;ZQ0-]8?J4@\IP2:N4XVN M014[K/3Z3T8XQ_0&TG1&5Y?"NL?II7$UNZ[-9;OU*U%45'7:_G(/H;(Y5D#H M0T(BP@D=/XCY!B-AHJ' '%03@?U$MOO_JHC6DDZ;7V(=5//$2MM[#$O4L*A= M/:*5+]RQI]%(>]8_'%P3 W-"VS@(92_:DD:Y-E+B3L&H8"K4<\L%*-TLFV%6 M"Q?C)F^#9B^MGY)PK"%$N[XF$X4J_@H D63P0W M0I"%25=,*!=?L/D48(@[ZN#?R>7JL%_)(J6+A' #![S)1JCLSQX+6SMQ+Y8^ MO/Y$\O]C%K_\#U!+ P04 " #+@SM3U/M@!W\$ U+P %0 &%S>&,M M,C R,3 Y,C=?<')E+GAM;-U:78_B-A1]K]3_D*;/(233[1:T[ HQLRM49@<- MK%KUI3*) 6N=&-EF@'_?:_-11L2):66D\0OY\+%]?'SCW!SSX=.VH,$+YH*P MLA6++PT\6IPCGX7;PO M/$$OFM[<:6S2Z71B77J""E(%A$:3^,_'T21;X@)%I%2:9(J+(%VA;XY8AJ06 MLG$(@1&AKJ(C+%*WHB2-[I+65N3A23C.*'[&\T =OST/7_6(Q#9K9:S0NK<[ M, $*%0-?B0M2XWDO5*U%QY84B9^O M;DCN5A W@A0KBL/X-(85QP(J:>@(;AS0BJR3\>QIX*W$$*=G6E*6O1JQZEH< MXTG@K+5@+W&.B>Y?G6@YM!1P\?>#[A#"'I%35Q3-,.V%IN(]$ZK"A?$S1?XG MDQ%>(+KOK[\EHH*, >&(S_UA7H;_SL44S2BN(-8$O1U#B$0\A,"JDL\&[ICI M%)JO879>[)C)&'/"\H*=<^WD.KSIQ.*@5(S'RK,'>F&-Z!XP)@@CAC]P8F$%'; BF)='A:SJF2E%N>(VX11DA$)7X^/$-2<(%I! MS QRQ&K,L5(!/FSU]\)4Y?_\:3ZOG,UF\&U8#H588WX55V,55[.-LS4$V2Y) M9U,B*_-Z$\01HRE'RKJ8[(H9JPJ]RG+'ZCQLLR4J%]B0B];!G+X#'@K,%R#& M%\XV<@EQM$+ESO@2J$4[XMF'H,Y58'^F:%'!K++]4/+U M*:(0SR[\E=<-'1#Q"G%EJ61+0O-C[3EG1;V1P)I,#VA>#_SM#KW1JF 67HNE M#,G;E\'>,SEJXE%@7(Z4V3H05FJ\K?@PJF%VKZQ42/U2H<8PLY+CS@\YKO:^ MK,3YQ2=Q3)Z;E1+O?%+"RMZSDN57GV1I=!.M)'GOMR3I?Y#D-P\E,;FE5H)T M/!2DUIFUR\^\2E>;C6 [43S)6LTNM)T,GJ2M]?:WG12>I*P6EKN='IYDJ4U. MOYT8GB2JMAL+=J)XDJ9>MX-A)XTGZ6K]UHF=%)ZDJ37;-G8Z>)*=-N\5V?EE M7F6E%CM3=JIXDI;6[(K9Z>!)7FJQ$W>V"Q-?2 (-?_]X*E$_ZA_9<.)^G0T *TM - 97A?,C@V-C0V+FAT;>5:;7,3 MMQ;^7'Z%FLZE,&,[=A(@Q"%3$PQ-24(F#NWMISORKNQ5L[O:2EH;]]??YQSM MKE^24$HO3.%VAL;>E73>G_,B'R8^2X\.$R7CHWO?''KM4W6DWOUG9__QX[W' M';P]W X/[WV#]]^VV^*5RI657L5BO!!729G'RKXPF1(7QGJ9BK9XNKWS9'NG MN],3O8.]O8-N3UR9>K8U,3:3OATK MKR*O3;XE(I-[E6.U5ZDJ$I.K9[G9.KIWN!UX/AR;>"&<7Z2\/?=MI_]0![UN MX?O\=2(SG2X.OK_2F7+B7,W%IBT]-YGTXMUHZJ]FYL M[=]&9B:MEKD_R$F"M)]).]7Y ;V&A..CX;M$C[473Y]V>H?;XZ/#[>+HWAWD M;K+Z5PG>S\>NZ+^/AKC_>VE\?X-2>-@72WJBU\.)8HVBJ$B*BJ9HI!PXE;O2 MB5&)%Q%\89#GILPCT+@H+0SOE# 3,5)Y(O$41,?&ZTB,%LZKC/SIU.!$,Q-G MQD5F+HY3G?-!HTC#"_0$BX_Q0=E_@A+_EE^(^M_NXZ ^?;0AO';")TI,M'5> M7);.X2"1&%=H"C-O!'3C-2)1R*5*&]57.BVLF5J)*-9?MKI X7(X&@XNCW\4 M5Y-.N_W@^=O1R?EP-!*_G%P.'P*H1JKP';'SI"4( MB_!@TSU;XB2/.N+!^:^CH1ADRN(AW'DP^O?QPQ:4FJF851FKF89J(Y,5,E_ M*-*3<6(]A?[_ (:PG32YY41BX5CYN5(Y/W6@I4PN9![S]T)Z\F0R7P& 4\J" M4 Z= %,I-BYP!LD.6[9?E3H&S!*[RB[N?[>_M[_3;V%K+!_)7G\9L8&GVKT $&EJYK4JBI5@ MO]LW.\@>I#8'=TXEP;VPJK *5O*KKG^G;T.'8R5*!U;GVB>0)\C1^=(]':;> MV>GV?T%D6P5-6)VF9&B6MY#6(P.3KDEJ>%B4P!N@2-@?:IRI%LQAY]+&;5+* M-:TD+6M?LI+Q4IC2;FJW-N6:*EO,2J\OG-0QX-PC R_$2V5S.+1IW0@I<0'[ MP6OAX>3QQ\,W';&4QB4DCZ1(RK3/JCB0\0P,$)=U<)C28XDB)["FG";L#&7P M)XJ5##X*I:4+R#63#B(+% Q);E)$ ;81Z=28ZUH/1"51:4$TZD!1[XHJ)C74 M,9FP1AW'9>#"=8CQWI-^]>=+=ZI-4WWOEDI#(",""7A:=X9;:STAP12$#_"N M." A%J82SDF04@ BZA,#/J5J!H2;DG'**5F> 0A%7:JGBJB1XJV9P7=$F:,( MC!*L*)9HR$:]TT$R&<%I%XN/M#%".6LE5Z_6(-$0\[LO MQ$R[4J;Z#T:[\'1-J4N=F>"38E=D&4>O+3/&Q0><5C MM]7GZG0\$"HGUEQC*&@"*FC'%L&;UWHBIR(:E?8(J&2304$?V%+ C)QF#*,( M-!C"W:K(3/.0C2.%1@1*,./?T$;4EA#-*H'\8;[BK&D',OY6:9M#R 2L433-K$FPT;I319""I)& M@9MYHN&)5?S6H82*X6O)S6^00+U"NJ22:4S5'O(P&ATW*2DOD3;)?3,J&!< M)4=5I$H-YZ!;\E?CCFN)C*&3,AJ) MJDU !96=$5F\-P"MC*@DL&^A2@(%60#P$)8=414@A&1E]E847Y?*D_EOYD%5#@SEM%2 6<) M);"FLLNZ54!HJQ7JGPMK)C Q['HRQ?]>@]2UF;7$CU!8C5T?7(A_SDB(]4Q$ M*9+8LZV+5\]?;]4DYSKV"9K\;O=?=3O?3M7$AYZ^?F*AR_"(1B1K9[V\NFP. M\^J=;P,?I^BA(A:Q+U8(;.Q-)FUKYC-5<+EQ?C(V-E:6)1:[6F.DCJH)4.\6[/H N M-5CV79?_PSZ$UA1Y/H_;ZZ]N*.#'%[)?O3D^1>'^7@4T>KA]OG/# M@5J"G\"34>E.UF<\*\:N++\IRN= 5AH@C1'2_T=#(%"X^BN8(1ZL+3\>'3^D M$@W>7<-/BK.IO C R15BW1:N-H'((32X;:JZBC* +$5+^4(1HE-=$$J658)$ M3XJL3+UNQ]I%N@"W$F <55RWJ$Q#QHN24%0@3^D\E&4L0@*NZ.O>_LJ I:8' M_U19D9H%YRN.0/&HVQ6QB;RQ+IRX4E5P;@#DYZ*WVT)\TE@$-1HR#\VH2=#; M):#A<9#^+DR7U :@'JN*N0].V5Q'5K5W2E2H!-SHC)!'D6/K@IRJ(C'2E%LI M-4Y(Z-"SBY]*$-SI0K:;4E#AX0IB#V4:]=PAG4'Y2,,TH*>K5M@99:MYKM7%^;5"[$F?0SI6"Y2%JKJ5XMR?NA MG<89PL"$""T]G ?2=3T18NBY-K7,+V4$3P?E"PU6H?IZ#GM>J_6R&B>":Y4TX$)Y_&9!FC@I(&JJP2"CDN=HO6N.]: 6B'(L/9%U7">-K"W M6,;>W7<5'SAIX!'#PW #0D#JEBJM.]8P$N!VN8%IMBCWU!#BEYH;N@6LV5X? M3K3N&%6%)!0K533CIO5VO1H140RL31K0Y4/3X8AY<(X\S"8-X2VMH=8QC@&. M82H4E=8RPC>YE:<+*RI+UFW)E,2]4.77W" M*1^8J3KB=(E5DD/X/=Y'YWR<=6J#KAC^!/GJ$.6LRSV8+D< M:KT=M<3P;4O\!)+Y\N*"N'$J12,G#'6@T%,)3^!D]Y+'2'1[DRI/O7$UOV5]8%1.I=UI?-P;\T^PR?4!\@ %(UP7SKP =M?5E<+ MI\8P\(R\]#Q"9J.-4UDM([Z:LQY/N'(_#+OU;A-Q>\ MU3T<%\)KES,;%)=W:82#2QZ)=(B%-<:G,!Z=R3= )15B- RNAC13(U/'Z8$; M!26VZAN4M#+W\JRM^J:(YYY*,@[R[3[_=$/L/!G4!14>E39@XR#BX.L]W=UE MBLWJWO"6U<-WU?AUN6VO&M7:&D##Q=CO-)F=+)I*DL9'*)'M&-]Y3)G6V"_0 M'@%:M$N6J>8"8$D7Z2ND3_%G&A+:I>*9?,/#TT>HU^G6;57;EL"6!\[$CM7N M.JB4[FAY'.V;@1ZM-1/PCG)A M.CP@S7'U1!TBC6JOK"@JRTFM/FB8[HM@/M MEJ09&CP5NSFWTUF*)H[P(LV9A.6FI!-YN1S$5?Z,HQ1[QWO]EV=T/(#\< ]> MNUF[I6^Z];*MDF[)4G7=]^?3\.STT(M)0J MXPBJ M^9H]QJ*FR@/NW+V?1_7\RSM/KOM[M[3IY]4\O(( M@(3T^,-&W?HIB1K[B8UY-GQQ,OALEGQMJ9/+D7<228!O6V+_T7Y[]]%>>W__ M4?=3DCY^A:)EHCZQAUR[6K(?HBG=,WZ(DWR.N/]T5V:G@]%5>WG)=.LEV/_T MK01I@-D+2S@PV[*^_[AD))"R,'3]"LLYNBDCSZ)Y^=\^, MCL=JXI/9Q _DN\)8J:A>*EU?7Q>O*\50C$IVK58KS;!/P72J"S;,=)P-A*^[ M.N7R00E:DX[8X/%%WVP_TYAT#2AW9;:G9&YQ%%Z5=!.,<>STO'PM"I42#Z2B M@8SD'"PJ&03"=Y,_C*5%2\XB5 MH),%O9C@;C)N*BUL6A)_2.5 CTI:-.VMLIU:W%0)-EK+@5H)VI>+6]?/KJ06 MF$)'A/X:='0+HE/.HB-5)/*%!ULRLG.#*UG1P>8!E0O1X3+<<^S#VX3-]%BP M83,/LO37>J!RE63?*(E:RC'?+,?6JO2K\33PF/#""41KE2@$VY,BD&TX#)>;Y\\>-&1ABC**Y\UM)%A2?/_JE^*8/>/2Z;QU4_0[Y^6 M1D;Z3H!Z2*7H5#4)Q:IE9Q##84X==NNVP?D\B.QK,:KXPE3 ME"!.%OMSRJ_>%5IAH%B@K#ZH1H&XYNE=0;&9*AFG4VHK$+D?JB.@70SKA_KQ.WOPY#=51GT^8).?LFG3#"0W,RR,24<\# MN:^3,@](N6CSX(@ 8V0HZH1.57@$A/'X50+)XS+R*4P*UI,5&O]X=2!>QX+X@?H=6Y4W"QGIKKH,#VD1_5]@004%1$$OMZ#%&0HJ MD_@"K6)=:I4&N$0[K_I8QP$H5%8B,47PM(6X&6W=NX+DD\AGR,082G9B_4*& M4Q$_:\]>CY=(N+=LMGL&E"G8 &-(S6U2SG,!F[;$LA[*WIG+0L02]!E3*TT&Q:D#!%L5)&%DL@ MMO#[*BV^:;WX944C?CE:JI'6(OUX106G@0(I@7##/YI0,>)!'9L1%3#J2+1Z M#9X+C3>O9[1\9 #W+%(P(X9'XU5G52B&6A7Z*-RO2[K/T=D0-TO(P$VV;-6 MFZZYI\:HT^6?H5\H8&5&\XY(C A,J4@992H/GOWX\,KP7PKF&MK>;G/RS55" M:1*3FF@"4Y^/ *P+5&8BA48>P=<@LX)%FLW.&C:G0,>04XP'BR@C&MPTOO:! M:1TT/IUW^NT3TNLW^^W><6D 9AN'0)/09-LTOM=N?>IV^IUVCS3/3TC[<^NW MYOE9F[0N/G[L]'J=B_/TI%^__G5BOFG]@\;O5([!;Z@PV"4G+>*4]_=J!J?G M1F:MUN7)SP,UP]F_51'18=ZJ%P^U.7<5^;OKW\%#] _DX/2B^Y'B$[6&[^(T_J[D%(.8%.8X_.YXQ"M)UGB2YUI-DV$:AQ MP"R"@0.(HYW#78(SYUJH!5-P('*@RR)(_,B.%S\#2!\XI0B[ CA$Z&;FO7VQ M;=MBVVZAVR$9=8BMBQ[V;IER;"OT MC.LY83Z]!D^5'Q(;7CXO'4#G-:88EX00CPCR!T0@TN,F8 F':>5^;M1XFJ : M0S&B ?]+/Z?-#B)64MY]I,YV?DZIT?W&.N7ME-A5@3SE/H,!$.IH*"LJMU,25DMFTYM0.G M7"UOE9QUBMUBKTC:D\@/YTRDTBY$9=#(KN=V48!?='"OX-?XNY)VOW_;I&Q5 M/)J>)YB4\<\''C#;B ;I_TZ:/IM1W$HC)X)?Y7O"06/WGG6G=8 =D_%-.7@X M^V"-2'Z+Z/4!RVO!/R]$/[P.3$PQ%6,Z>0HZZL#@0EQ"R,-Q#Y?,7>:> MV/#F==6Q#X^@01+%?!;AQ"30,^]"/NKZ4TQU",36%##SV)VX_AV;9=#$4)%F M%/G@LL#YK%#O%&8!$VL2>:%3&7BD1F& 8$-BJHL0EJ!J$Y_*I(*U'?JRU>G\ M]R$W?TPE1#3S+.#6F+E?L/!,: 2Y+-A-3/X&X8P,F!]>HV1@(\H/J5KOR5 ? MG2)<@I(I!G[;PWJVY).IKVC PJGTYT1"T"2'!" M3H\B46IGHSN%Q&G/V8]YBLQ,;6+@WL6.?4A:IUWB5,I%Z/CV>Z=D+P23"\L+ M1A]!=0"NOXF,RQ& EQERDX;V'K5L)T7&S ;0@HA[Y:+I^=W3\5(PE$8\(Z5W MC-&XB(OA$$.%V^D)(RTW-72C?-I[GN7L#-[>C;JF[X]&WXZ44R:>E,H59NWM MN'>C5C;$ILH)<) MZ/0>A,'$\ME0U?7IUOB%T*%B?-YUPS:%P=4:A$J%D[H$N^UAC+D((%>*=Z9? MC$3%*5:^0?ENT.CCL66S(>V.B0NAO+QW"3.S$MLL9'T-\YYDPA)G3*-*\>#; MT$A0G1_*^600^OBITOVQ3B?M?Y6*Y;).("G)%_2DC M$9X4'R]V&Y_,&FR;MM^+Q;%AZ&F[H.G8['W.K7$^E<'X#C5D-09%BW%S4SS1 MGB0(-*=?T-K\I]Y&ZNW= L=.X&'HSO RDZN+0-#\!0P\T[O^ M*Q4:+@D-",3].,.(C$1XK<:8 418M:&2>&S( W,4R)0 ROM)K+F2_YNSBQ6R M\^:U?7!XI,L 26>N#Q%%>(@(RY0FC7 &EI,S5]Z!R,6DF%(LQZ6F+6X+_QX[ M75S\U4?9"HUV/J\,FCVYM*IGL!8^)J*]Y5Y#JC,Y>FD$4:EC]'X-<<0*-2 M!K <:!'LBDL8!^I) Q=+3=35MT)U^*MHX%'A25-G]=:ECI4=ND@=TWI73(O3 M@LE/2^R--Z^>X";4K3>OGN"FU]UN7CV)>NA\\5WA\NS7]XL$/(-Q.J_6=2J2 M2:SQ5:&Q,M=IO[N8+&__)@5@9>QX:($VW7R)I0)R>7;^Z>/**K(_:7Y=-L_: MUJ_==O.]U3SMM[MU0OUK.I>K3,BL-F&R" M;;S,((MK<-W>./QA;B8M;A5S5?,"Z@"\73 M"T[YJ)6$9/!D'[V%0 %K\AX,C?0Y%@&Q 7_3X, ; RJ!_D0 H;A%?D82C>\ M)BV?8P'>)SV7Q^?52$O;U%WBAZ[^6 $/#,',D%T(JJ7D=%<'&S!:<=-+P1)8 M,,:O5D ,?;AW!'2#O!\FQ)4Q,<<0823H)+4YBVN!> 'B :G+170QQ8(7 M0+,BZ4-?_5D,WS>4$ Q7B<(5[Q,+J=:.QVADP# :\G2$DRS*+&9K@OI'%[HF M"$^TV!;/B@5D-4/N T% 39D)^S K&O,!5Z16*]H@.,C^1/SBGI"A01RZ^![! M\]/NQ1_D^(,:^(/M=@>GBP1"GP.<:,U%"8M%3A:WUD5LL<3%>OZ,K-SQWFZI MD,6"]")"7R5"ZRO*<;^J_>S&+?WM"SVUQ]PX$JJ;8P'X';0EZ\T:SL-B]G,7 M=Q!4DMUGPZ(?0-:[;6(TV"GO$OS_[?.N_X1)5_ (E_LBU#^*4&-DM:4&])@2 M\W4J-ON?4STXV#O #YDMV(8%7 L "NJJ.C,:!Z,N,U&EIP/%O#OQ],6Y_S!" M;)?WME2&6R%0F%S2$8-$&A)9D%6\O'%"%27Z5MZ.V9)0\;US_25-@I_2S EK MMD \7VJJ+S75QZ^I/N=!DE[G[+S9_]1-OF[V@Y9:TM_G,?MR?TZYB//BO:7*N)*UH2" \-H?F"QH"-J3_$^@Q.I -DTT'/+-@T M@%%Z0C#,XU# $"I?=[[U".]3]VS M3JOY89=TSENW%V/R3N8],XU6Z++_V'2YT])C&-K$YM%AK5-Y%,K@AZ3JN:%V M+L7RD W":T$C]++XNT"OLKS0MH"(ATYS$N+'I?J-CUU^O4J79"FQ.[H6T!O3 M"?N+D2Z=1!"#T\'?6+I?:+&$VEY<\/XW=QE>4Y'ZZ\:Z-MT:7L.UMXN/ ILZ /S5[?6N8-N7G-O?.56Q*A0L.Y-8:'?\0< MQ^^N-_X/4$L! A0#% @ RX,[4Y5(LK-P P )PX !$ M ( ! &%S>&,M,C R,3 Y,C'-D4$L! A0#% @ RX,[4P'X(L'G M! 9BX !4 ( !GP, &%S>&,M,C R,3 Y,C=?9&5F+GAM M;%!+ 0(4 Q0 ( ,N#.U,&$FA7#P8 &L^ 5 " ;D( M !A&UL M4$L! A0#% @ RX,[4S?AXGZ=#0 K2T T ( !K1, M &5X7S(X-C8T-BYH=&U02P$"% ,4 " #+@SM3W9!Q8)8/ 79 %0 M @ %U(0 =')A;G-E,C R,3 Y,C=?.&LN:'1M4$L%!@ & - 8 A@$ #XQ $! end